OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ)

CUSIP: G6S41R101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / SHS
Total 13F shares
24,083,548
Share change
-1,094,872
Total reported value
$13,488,979
Put/Call ratio
1.8%
Price per share
$0.56
Number of holders
35
Value change
-$736,573
Number of buys
5
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP G6S41R101?
CUSIP G6S41R101 identifies RVLPQ - OSMOTICA PHARMACEUTICALS PLC - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) as of Q2 2023

As of 30 Jun 2023, OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,083,548 shares. The largest 10 holders included Athyrium Capital Management, LP, Rovida Advisors Inc., ArrowMark Colorado Holdings LLC, AIGH Capital Management LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Worth Venture Partners, LLC, UBS OCONNOR LLC, and VANGUARD GROUP INC. This page lists 35 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.